2-11713973-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001261428.3(LPIN1):​c.138+161T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.397 in 152,216 control chromosomes in the GnomAD database, including 14,191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 14191 hom., cov: 33)

Consequence

LPIN1
NM_001261428.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0560

Publications

1 publications found
Variant links:
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
  • myoglobinuria, acute recurrent, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Laboratory for Molecular Medicine, PanelApp Australia
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-11713973-T-C is Benign according to our data. Variant chr2-11713973-T-C is described in ClinVar as Benign. ClinVar VariationId is 683085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001261428.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
NM_001261428.3
c.138+161T>C
intron
N/ANP_001248357.1Q14693-7
LPIN1
NM_001349207.2
c.81+36245T>C
intron
N/ANP_001336136.1
LPIN1
NM_001349208.2
c.138+161T>C
intron
N/ANP_001336137.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
ENST00000449576.6
TSL:2
c.138+161T>C
intron
N/AENSP00000397908.2Q14693-7
LPIN1
ENST00000852426.1
c.-10+161T>C
intron
N/AENSP00000522485.1
LPIN1
ENST00000961822.1
c.-10+161T>C
intron
N/AENSP00000631881.1

Frequencies

GnomAD3 genomes
AF:
0.397
AC:
60433
AN:
152098
Hom.:
14190
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.133
Gnomad AMI
AF:
0.477
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.520
Gnomad EAS
AF:
0.432
Gnomad SAS
AF:
0.552
Gnomad FIN
AF:
0.492
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.502
Gnomad OTH
AF:
0.437
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.397
AC:
60440
AN:
152216
Hom.:
14191
Cov.:
33
AF XY:
0.400
AC XY:
29783
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.133
AC:
5516
AN:
41552
American (AMR)
AF:
0.484
AC:
7404
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.520
AC:
1805
AN:
3468
East Asian (EAS)
AF:
0.432
AC:
2233
AN:
5174
South Asian (SAS)
AF:
0.553
AC:
2670
AN:
4830
European-Finnish (FIN)
AF:
0.492
AC:
5208
AN:
10586
Middle Eastern (MID)
AF:
0.442
AC:
129
AN:
292
European-Non Finnish (NFE)
AF:
0.502
AC:
34112
AN:
67994
Other (OTH)
AF:
0.440
AC:
929
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1675
3351
5026
6702
8377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.423
Hom.:
1999
Bravo
AF:
0.381
Asia WGS
AF:
0.506
AC:
1758
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.4
DANN
Benign
0.55
PhyloP100
-0.056
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4668739; hg19: chr2-11854099; API